A new decade presents an opportunity for reflection. For Healthcare Distribution Alliance and our pharmaceutical distributor members, 2020 finds us reexamining the value our industry provides to the larger health care ecosystem while reassessing our priorities and anticipating what is around the corner. HDA captured the state of our industry, and what the future may
ARLINGTON, Va. — John Gray, president and chief executive officer of the Healthcare Distribution Alliance (HDA), announced on Monday his retirement from the organization. Gray will remain in his position until May 2, 2020. Gray, who has led HDA (formerly known as the Healthcare Distribution Management Association) since 2004, is credited with restructuring and streamlining
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray issued the following statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers: “The DEA has taken an important step to enhance data transparency and address a
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) announced today the election of Greg Drew, president of Value Drug Company, as chairman of HDA’s board of directors. Robert Mauch, executive vice president and group president at AmerisourceBergen Corporation, was elected vice chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting. Drew,
ARLINGTON, Va. — Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines. AAOA, along with its founding member, the Healthcare Distribution Alliance (HDA),
ARLINGTON, Va. —Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies: “HDA and the nation’s primary pharmaceutical distributors appreciate the Trump administration’s efforts
COLORADO SPRINGS, Colo. — The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael Conley of Novartis Pharmaceuticals Corp. with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the
COLORADO SPRINGS, Colo. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference here. The DIANA Awards have been a symbol of excellence in the pharmaceutical supply chain since 1959.
STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to health care around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and CEO John Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation
WASHINGTON — The President’s Commission on Combating Drug Addiction and the Opioid Crisis has issued its final report, which includes 56 recommendations to the Trump administration to help fight opioid abuse. President Donald Trump formed the presidential commission, chaired by New Jersey Gov. Chris Christie (R.), in a March 29 executive order as a way
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
ARLINGTON, Va. — Cardinal Health executive Jon Giacomin has been elected to a second term as chairman of the Healthcare Distribution Alliance board of directors. HDA announced the re-election of Giacomin, chief executive officer of Cardinal Health’s pharmaceutical segment, at the 2017 HDA Annual Board and Membership Meeting, held Sept. 24 to 27 in Laguna
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) plans to hold the 2017 International Pharmaceutical Distribution Conference (IPDC) this fall in Geneva, Switzerland. HDA said the fourth annual event, scheduled for Oct. 16 and 17 at the Grand Hotel Kempinski Geneva, will be held in partnership with the Swiss Pharma Logistics Association (Pharmalog.ch), European Healthcare